Home Our expertise Commercialization platform

Our scaled commercialization platform.

Our experts are empowered to help you confidently navigate each pivotal moment across the complex lifecycle of your asset, overcoming any challenge together.

Seamlessly connecting best-in-class capabilities across health and life sciences.

Our connected capabilities uniquely position us to support you in your high-stakes journey to bringing your pharmaceutical assets to market. We understand the complexity of your journey and the critical moments that significantly impact the success and pace of bringing your asset to patients in need.

By leveraging our extensive scientific knowledge, market intelligence, actionable data, cutting-edge tech, communication and creative execution, we provide comprehensive support from the earliest discovery stages through to post-launch activities to maximize the value of your asset.

Inizio Advisory

From science to strategy.

 

Creating long-term value for patients through end-to-end advisory services.

  • Strategy Development
  • Transformation & Execution
  • Portfolio Licensing & Development
  • Product Launch
  • Est. Product & Franchise Strategy
  • Health Economics & Outcomes Research
  • Value, Pricing & Access
  • Market Research & Insights
  • Clinical Trial Feasibility & Patient Retention Support
  • Competitive Intelligence
  • Strategic Benchmarking
  • Operating Model & Organisation Design
  • DEI & Culture Creation
  • Technology Transformation
  • Customer Experience Innovation

Inizio Medical

Delivering on the power of Medical

 

Creating compelling content to achieve outcomes that matter.

  • Medical Affairs Strategy and Planning
  • Publications Planning
  • Gap Analysis & Evidence Planning
  • Medical Education
  • Congress Planning & Engagement
  • MSL Strategy, Training, Effectiveness & Content
  • Medical & HEOR Writing
  • Data Strategy, Insights & Analytics
  • KOL Mapping, ID & Development
  • Patient Engagement
  • Scientific Platform Development & Core Scientific Statements

Inizio Evoke

Health communications more human.

 

Global brand, experience and communications platform.

  • Creative
  • PR, Comms & Policy
  • Market Access
  • Data, CX & Omnichannel
  • Marketing Technology
  • Media & Activation
  • Production & Delivery
  • Commercial Impact
  • DTC Marketing
  • HCP Marketing
  • Launch Strategy & Execution

Inizio Engage

Commercialization and strategic engagement.

 

Creating personalized experiences that deliver improved treatment outcomes.

  • Patient & HCP Treatment Experience Design
  • Data & Integrated Insights
  • Market Access
  • Employee Engagement
  • Learning & Capabilities
  • Events Creative, Production, Logistics & Exhibition
  • Digital & Film
  • Behavioral Science
  • Patient Support, Access & Adherence
  • Treatment Navigation
  • Field Reimbursement
  • Medical Science Liaisons
  • Medical Information
  • HCP Education & Promotion
  • Omnichannel Consulting & Analytics
  • Key Account Management

Immersed in your needs. Dedicated to your outcomes.

We are a launch powerhouse in the market, entrusted by our clients to activate their maximum potential and make a difference in patients’ lives.

From 2021 to 2023, we’ve successfully:

Partnered on 1,100 assets and on 19 of the top 20 performing products with a value in excess of $484 billion

Supported 50% of product launches across 11 of 14 therapeutic areas

Partnered on 62% of top 20 pharmaceutical product launches, with 42% projected to be blockbusters (2021-2028)

Contributed to all 25 projected blockbusters expected in the next decade

Supported 95% of top products in 2022

Worked with 100% of our client base in the top 20 pharma companies

Worked on some of the highest-value assets within the fastest-growing therapeutic areas. Our comprehensive coverage of these areas, when compared to the prescription sales share from 2021 – 28, demonstrates our strong presence across the entire market, including:

  • Oncology = 80%
  • Immunology = 81%
  • Dermatology = 56%

Connected capabilities.

Connected by a diverse collective of 11,700 experts across 50 countries, our market-leading commercialization platform for pharma and biopharma brings unrivaled scientific knowledge, subject matter expertise, ingenuity, and agility to even your most complex projects.

It's time to reimagine health.

We help our clients navigate each pivotal moment in their clinical development and commercialization journey so that more people get the treatments they need, faster.